Cardiovascular disease accounts for 24% of deaths in Australia and includes a wide range of diseases and conditions affecting the heart and blood vessels. The Centre for Cardiovascular Health and Research (CCVHR) brings together a multidisciplinary team of researchers at The University of Queensland with the shared goal of reducing the burden of cardiovascular disease in Australia, and globally.
The Centre serves as a dynamic hub, uniting experts from within the university and beyond to foster collaboration, inspire innovation, and advance our understanding of cardiovascular health. Through this cross-disciplinary approach, the CCVHR aims to develop new insights and therapies that will transform outcomes for individuals and communities affected by cardiovascular disease.
The CCVHR serves as a vehicle to formalise and accelerate ongoing efforts in cardiovascular research at UQ. With this centre, UQ will lead a consortium of activities from fundamental to translational research, as well as development of industry links and public advocacy.
The Centre’s work is organised into 6 research themes that each address a key element of pain within an integrated framework:
Mechanisms underlying cardiac homeostasis and disease
The CCVHR integrates expertise in heart development, disease mechanisms, exercise physiology, stem cell and organoid models, and clinically relevant large animal studies to uncover pathways driving cardiovascular disease and identify therapeutic targets.
Learn more about the Mechanisms underlying cardiac homeostasis and disease theme.
Preclinical modelling of vascular biology and disease
The CCVHR unites leading expertise in vascular biology, immunology, physiology and genomics with cutting-edge preclinical models to uncover molecular pathways and therapeutic targets for vascular diseases, while integrating closely with cardiac research for a holistic approach to cardiovascular health.
Learn more about the Preclinical modelling of vascular biology and disease theme.
Genomics of cardiovascular disease
The CCVHR leverages human genomics and genetic epidemiology to uncover disease mechanisms, improve risk prediction, and identify validated therapeutic targets, with projects spanning heart failure, inherited cardiac disease, and large-scale genomic studies.
Learn more about the Genomics of cardiovascular disease theme.
Cardiovascular bioengineering
The CCVHR develops advanced bioengineered cell culture platforms to better model cardiovascular function, enabling discovery and manufacture of novel therapeutics—including engineered grafts, exosomes, and cell and gene therapies with applications across heart and vascular disease.
Learn more about the Cardiovascular bioengineering theme.
Cardiovascular therapeutics
The CCVHR leverages its therapeutic development expertise to partner with local and international biotechnology and pharmaceutical companies, advancing cardiovascular research and clinical translation.
Learn more about the Cardiovascular therapeutics theme.
Clinical research/public health
The CCVHR integrates clinical expertise across cardiovascular diseases, biomedical devices, biomarkers, exercise physiology, rehabilitation, and cardio-oncology with biomedical research to drive translational discoveries, patient-focused trials, and improved clinical guidelines.
Co-Directors
Theme leads
- Dr Jacky Suen
- Professor Wally Thomas
- Dr Mark Allenby
- Professor Mark Midwinter
- Associate Professor Sonia Shah
- Associate Professor Joy Wolfram
- Professor Nathan Palpant
- Dr Monica Ng
- Dr Shelley Keating
Research leaders
- Professor John Atherton
- Dr Matilde Balbi
- Professor Lauren Ball
- Dr Rosemary Cater
- Dr Wandy Chan
- Professor Simon Cool
- Professor Jeff Coombes
- Professor Justin Cooper-White
- Dr Mark Coulthard
- Dr James Cuffe
- Associate Professor Jayesh Dhanani
- Dr Simon Foster
- Professor John Fraser
- Professor J Hudson
- Dr Shelley Keating
- Dr John Kemp
- Professor Glenn King
- Professor Karam Kostner
- Dr Larissa Labzin
- Dr Scott McKenzie
- Professor Mark Midwinter
- Associate Professor Dominic Ng
- Professor Michael O’Sullivan
- Dr Pranesh Padmanabhan
- Professor Marc Ruitenberg
- Dr Daniel Schweitzer
- Associate Professor Sandhir Prasad
- Professor Kirsty Short
- Professor Fiona Simpson
- Dr Jenna Taylor
- Dr Antonio (Tony) Tsahtsarlis
- Professor Jana Vukovic
- Dr Nicole Warrington
- Dr Yong Chen Wee
- Dr Craig Winter
- Associate Professor William Wang
- Dr Mel White
- Professor Trent Woodruff
News
SMART move: UQ to host national push for next-gen therapy manufacturingHeart Foundation: A living lab for global heart disease actionStaying physically active cuts risk of early death by 40 per cent (UQ News, 11 July 2025)King’s Birthday honours for UQ staff and alum (UQ News, 9 June 2025)Culturally tailored interventions key to combatting early onset type 2 diabetes (UQ News, 26 February 2025)Study exposes link between genetic risk of depression and heart disease in women (UQ News, 5 December 2024)Long COVID inflammation damages the heart (UQ News, 31 October 2024)UQ researchers support cardiovascular research (UQ News, 29 October 2024)Spider venom heart drug moves to clinical trials (UQ News, 7 October 2024)Hearts by design (UQmedicine Magazine, Summer 2021)
Contact us
Get in touch to learn more about our research.
Dr Melissa Reichelt
Co-Director
Associate Professor Anne Lagendijk
Co-Director